Pancreatic Cancer Trial, Recruiting (NCT07436312)

Pancreatic Cancer Trial, Recruiting NCT07436312 Sponsor: Gustave Roussy, Cancer Campus, Grand Paris Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07436312 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older
People who have been identified as having an increased risk of certain cancers, as defined by the Interception program
People whose baseline WCRF (World Cancer Research Fund) lifestyle score was 5 or lower when they entered the Interception program (confirm with trial site)
People who have agreed to take part and have signed a written consent form
People who agree to complete questionnaires on a dedicated online platform for the full duration of the study
People who own and are willing to use a smartphone
People who can understand and communicate in spoken and written French

Who may not be able to join:

People with psychiatric conditions or cognitive difficulties that would prevent them from taking part
People who are under legal guardianship, have had their liberty restricted by a court or administrative decision, or are unable to give their own consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bruno Raynard, MD, Gustave Roussy, Villejuif, France

Phone: +33 (0) 1 42 11 42 11

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07436312

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: +33 (0) 1 42 11 42 11

More information: https://clinicaltrials.gov/study/NCT07436312

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older
People who have been identified as having an increased risk of certain cancers, as defined by the Interception program
People whose baseline WCRF (World Cancer Research Fund) lifestyle score was 5 or lower when they entered the Interception program (confirm with trial site)
People who have agreed to take part and have signed a written consent form
People who agree to complete questionnaires on a dedicated online platform for the full duration of the study
People who own and are willing to use a smartphone
People who can understand and communicate in spoken and written French

Who may not be able to join:

People with psychiatric conditions or cognitive difficulties that would prevent them from taking part
People who are under legal guardianship, have had their liberty restricted by a court or administrative decision, or are unable to give their own consent

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Registry

ClinicalTrials.gov

Start date

4 May 2026

Est. completion

1 September 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Proportion (%) of participants with at least 1-point improvement in the WCRF score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov